ciprofloxacin injection, USP (1% w/v)
and
ciprofloxacin in dextrose (5%) injection, USP
(ciprofloxacin)
For Intravenous Infusion
WARNING
Fluoroquinolones, including Ciprofloxacin Injection, USP, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants (See WARNINGS).
To reduce the development of drug-resistant bacteria and maintain the
